tradingkey.logo

Abbott Laboratories

ABT
View Detailed Chart
108.500USD
-12.230-10.13%
Market hours ETQuotes delayed by 15 min
188.67BMarket Cap
13.51P/E TTM

Abbott Laboratories

108.500
-12.230-10.13%
Intraday
1m
30m
1h
D
W
M
D

Today

-10.13%

5 Days

-13.20%

1 Month

-13.51%

6 Months

-12.80%

Year to Date

-13.40%

1 Year

-7.10%

View Detailed Chart

TradingKey Stock Score of Abbott Laboratories

Currency: USD Updated: 2026-01-21

Key Insights

Abbott Laboratories's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 40 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 144.08.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Abbott Laboratories's Score

Industry at a Glance

Industry Ranking
40 / 206
Overall Ranking
116 / 4548
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

49°C

Very Low
Very High
Negative

Abbott Laboratories Highlights

StrengthsRisks

Abbott Laboratories is an American multinational health care and medical devices corporation headquartered in Abbott Park, Illinois. Founded in 1888 by Chicago physician Wallace Calvin Abbott, the company initially focused on formulating known drugs. Today, it offers medical devices, diagnostics, branded generic medications, and nutritional products. In 2013, Abbott separated its research-based pharmaceuticals division into AbbVie.

Abbott's product lineup includes Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.

Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 41.95B.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 41.95B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 29.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 29.13%.
Undervalued
The company’s latest PE is 15.03, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.42B shares, increasing 0.28% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 215.00 shares of this stock.

Analyst Rating

Based on 31 analysts
Buy
Current Rating
144.077
Target Price
+18.33%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Abbott Laboratories Info

Abbott Laboratories is an American multinational health care and medical devices corporation headquartered in Abbott Park, Illinois. Founded in 1888 by Chicago physician Wallace Calvin Abbott, the company initially focused on formulating known drugs. Today, it offers medical devices, diagnostics, branded generic medications, and nutritional products. In 2013, Abbott separated its research-based pharmaceuticals division into AbbVie.

Abbott's product lineup includes Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.

Ticker SymbolABT
CompanyAbbott Laboratories
CEOFord (Robert B)
Websitehttps://www.abbott.com

FAQs

What is the current price of Abbott Laboratories (ABT)?

The current price of Abbott Laboratories (ABT) is 108.500.

What is the symbol of Abbott Laboratories?

The ticker symbol of Abbott Laboratories is ABT.

What is the 52-week high of Abbott Laboratories?

The 52-week high of Abbott Laboratories is 141.230.

What is the 52-week low of Abbott Laboratories?

The 52-week low of Abbott Laboratories is 113.500.

What is the market capitalization of Abbott Laboratories?

The market capitalization of Abbott Laboratories is 188.67B.

What is the net income of Abbott Laboratories?

The net income of Abbott Laboratories is 13.40B.

Is Abbott Laboratories (ABT) currently rated as Buy, Hold, or Sell?

According to analysts, Abbott Laboratories (ABT) has an overall rating of Buy, with a price target of 144.077.

What is the Earnings Per Share (EPS TTM) of Abbott Laboratories (ABT)?

The Earnings Per Share (EPS TTM) of Abbott Laboratories (ABT) is 8.031.
KeyAI